These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update. Fisher A; Heldman E; Gurwitz D; Haring R; Karton Y; Meshulam H; Pittel Z; Marciano D; Brandeis R; Sadot E; Barg Y; Pinkas-Kramarski R; Vogel Z; Ginzburg I; Treves TA; Verchovsky R; Klimowsky S; Korczyn AD Ann N Y Acad Sci; 1996 Jan; 777():189-96. PubMed ID: 8624083 [TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells. Danenberg HD; Haring R; Heldman E; Gurwitz D; Ben-Nathan D; Pittel Z; Zuckerman A; Fisher A Ann N Y Acad Sci; 1995 Dec; 774():300-3. PubMed ID: 8597471 [TBL] [Abstract][Full Text] [Related]
5. NGF-dependent neurotrophic-like effects of AF102B, an M1 muscarinic agonist, in PC12M1 cells. Gurwitz D; Haring R; Pinkas-Kramarski R; Stein R; Heldman E; Karton Y; Fisher A Neuroreport; 1995 Feb; 6(3):485-8. PubMed ID: 7766849 [TBL] [Abstract][Full Text] [Related]
6. Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum. Pittel Z; Heldman E; Barg J; Haring R; Fisher A Brain Res; 1996 Dec; 742(1-2):299-304. PubMed ID: 9117408 [TBL] [Abstract][Full Text] [Related]
7. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998 [TBL] [Abstract][Full Text] [Related]
8. Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands. Gurwitz D; Haring R; Heldman E; Fraser CM; Manor D; Fisher A Eur J Pharmacol; 1994 Mar; 267(1):21-31. PubMed ID: 8206127 [TBL] [Abstract][Full Text] [Related]
9. Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists. Beach TG; Walker DG; Potter PE; Sue LI; Fisher A Brain Res; 2001 Jun; 905(1-2):220-3. PubMed ID: 11423097 [TBL] [Abstract][Full Text] [Related]
10. AF102B, a muscarinic M1 receptor agonist, mimics some effects of acetylcholine on neurons of rat hippocampus slices. Segal M; Fisher A Eur J Pharmacol; 1992 Sep; 220(1):103-6. PubMed ID: 1425975 [TBL] [Abstract][Full Text] [Related]
11. Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. Sadot E; Gurwitz D; Barg J; Behar L; Ginzburg I; Fisher A J Neurochem; 1996 Feb; 66(2):877-80. PubMed ID: 8592166 [TBL] [Abstract][Full Text] [Related]
12. Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells. DeLapp N; Wu S; Belagaje R; Johnstone E; Little S; Shannon H; Bymaster F; Calligaro D; Mitch C; Whitesitt C; Ward J; Sheardown M; Fink-Jensen A; Jeppesen L; Thomsen C; Sauerberg P Biochem Biophys Res Commun; 1998 Mar; 244(1):156-60. PubMed ID: 9514902 [TBL] [Abstract][Full Text] [Related]
13. Progress in medicinal chemistry of novel selective muscarinic agonists. Fisher A; Karton Y; Heldman E; Gurwitz D; Haring R; Meshulam H; Brandeis R; Pittel Z; Segall Y; Marciano D Drug Des Discov; 1993; 9(3-4):221-35. PubMed ID: 8400004 [TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion. Haring R; Fisher A; Marciano D; Pittel Z; Kloog Y; Zuckerman A; Eshhar N; Heldman E J Neurochem; 1998 Nov; 71(5):2094-103. PubMed ID: 9798935 [TBL] [Abstract][Full Text] [Related]
15. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study. Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909 [TBL] [Abstract][Full Text] [Related]
16. Receptor-coupled amyloid precursor protein processing. Nitsch RM; Slack BE; Farber SA; Borghesani PR; Schulz JG; Kim C; Felder CC; Growdon JH; Wurtman RJ Ann N Y Acad Sci; 1993 Sep; 695():122-7. PubMed ID: 8239269 [TBL] [Abstract][Full Text] [Related]
17. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats. Fisher A; Brandeis R; Pittel Z; Karton I; Sapir M; Dachir S; Levy A; Heldman E Neurosci Lett; 1989 Jul; 102(2-3):325-31. PubMed ID: 2812509 [TBL] [Abstract][Full Text] [Related]